Princeton, NJ, United States of America

Laurence David Toms

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurence David Toms. Retrieved from https://idiyas.com/inventor/laurence-david-toms

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laurence David Toms: Innovator in Lung Cancer Therapy

Introduction

Laurence David Toms is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of medical research, particularly in cancer therapy. His work focuses on innovative treatments that aim to improve patient outcomes.

Latest Patents

Toms holds a patent for "LAG-3 Antagonist Therapy for Lung Cancer." This patent represents a crucial advancement in the fight against lung cancer, showcasing his commitment to developing effective therapeutic options.

Career Highlights

Laurence David Toms is associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm. His role at the company allows him to leverage his expertise in research and development to create impactful medical solutions.

Collaborations

One of his notable collaborators is Paul Andrew Basciano. Together, they work on innovative projects that aim to enhance cancer treatment methodologies.

Conclusion

Laurence David Toms is a dedicated inventor whose work in lung cancer therapy exemplifies the importance of innovation in medicine. His contributions continue to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…